James L Reading PhD; Nature 2026: Regulatory T-Cell Axis Identifies Pre-Malignant Lung Cancer
James L Reading
LONDON, United Kingdom—Researchers in London have identified patterns of regulatory T-cells that give early warning of high risk for lung cancer. The journal Nature has just published research showing that lung cancer could be intercepted through blood tests years ahead of current screening and diagnostics, and treated with safe targeted drugs some of which are already under investigation. Peter Goodwin called into the Pre-cancer Immunology Laboratory at University College London to hear from the senior author of this research, James Reading PhD.
Regulatory T-Cell Axis Identifies Early Pre-Malignant Lung Cancer
An interview with:
James L Reading, Associate Professor of Cancer Immunology, Group Leader, Pre-cancer Immunology Laboratory, University College of London Cancer Institute, London UK
LONDON, United Kingdom—Researchers in London have identified patterns of regulatory T-cells that give early warning of high risk for lung cancer. The journal Nature has just published research showing that lung cancer could be intercepted through blood tests years ahead of current screening and diagnostics and treated with safe targeted drugs, some of which are already under investigation. Peter Goodwin called into the Pre-cancer Immunology Laboratory at University College London to hear from the lead author of this research, James Reading PhD.
AUDIO JOURNAL OF ONCOLOGY: James L Reading PhD
Source:
A preinvasive regulatory T cell axis for lung cancer interception